Related Experiment Video
Updated: Jun 27, 2026

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Orbital metastasis from medullary thyroid carcinoma
Bryan D Seiff1, Stuart R Seiff
1Ophthalmic Plastic and Reconstructive Surgery, Department of Ophthalmology, University of California-San Francisco, San Francisco, California, USA. bryanseiff@yahoo.com
Ophthalmic Plastic and Reconstructive Surgery
|November 27, 2008
Summary
A rare case of medullary thyroid carcinoma metastasis to the eye muscle caused progressive double vision and eye protrusion in a patient with multiple endocrine neoplasia type 2A. Surgical removal offered palliative benefits.
Area of Science:
- Ophthalmology
- Endocrinology
- Oncology
Background:
- Multiple endocrine neoplasia type 2A (MEN2A) is a rare genetic disorder.
- Medullary thyroid carcinoma (MTC) is a common manifestation of MEN2A.
- Orbital involvement in MTC is exceptionally rare.
Observation:
- A 46-year-old woman with MEN2A presented with unilateral proptosis and diplopia.
- Clinical and imaging findings suggested thyroid-associated orbitopathy.
- A progressive increase in the size of the left inferior rectus muscle was noted on CT scans.
Findings:
- Excisional biopsy confirmed metastasis of MTC to the left inferior rectus muscle.
- This represents a rare instance of MTC orbital metastasis.
- Unilateral proptosis necessitates investigation for intraorbital or intracranial disease.
Implications:
- Early detection of MTC metastasis is crucial for patient management.
- Surgical debulking can alleviate compressive symptoms and prevent damage to vital structures.
- Multidisciplinary care involving ophthalmology, oncology, and endocrinology is essential for optimizing treatment outcomes in metastatic MTC.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

